Activation of the PD1/PD-L1/L2 pathway inhibits T cell proliferation and secretion of interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α), and IL-2, sustaining the immune inhibitory state of the tumor microenvironment (9). Here, IFNG is linked to neoplasm.